Amrutanjan Healt

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE098F01031
  • NSEID: AMRUTANJAN
  • BSEID: 590006
INR
659.90
-6.15 (-0.92%)
BSENSE

Dec 05

BSE+NSE Vol: 9.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'17
Mar'16
Mar'15
Mar'14
Mar'13
Mar'12
Mar'11
Net Sales
231.70
194.52
165.78
140.41
136.66
142.93
105.41
Other Operating Income
2.88
1.28
0.79
1.32
0.99
0.22
0.00
Total Operating income
234.59
195.80
166.57
141.73
137.65
143.15
105.41
Raw Material Cost
72.83
60.23
57.53
53.07
55.99
60.43
41.70
Purchase of Finished goods
15.68
6.27
4.96
3.07
3.18
5.14
2.10
(Increase) / Decrease In Stocks
-1.93
0.58
0.27
0.86
0.98
-0.76
-0.54
Employee Cost
33.58
28.55
25.98
22.82
21.03
19.58
16.33
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
37.41
30.78
27.23
23.53
22.31
22.69
17.49
Selling and Distribution Expenses
37.38
29.67
26.86
16.66
16.74
18.02
0.00
Other Expenses
10.61
9.05
0.00
0.00
0.00
0.02
15.39
Total Expenditure (Excl Depreciation)
205.57
165.13
142.82
120.02
120.24
125.12
92.46
Operating Profit (PBDIT) excl Other Income
29.02
30.66
23.74
21.71
17.41
18.02
12.95
Other Income
4.83
5.68
4.54
2.94
4.27
4.60
4.80
Operating Profit (PBDIT)
33.85
36.34
28.28
24.66
21.68
22.63
17.75
Interest
0.43
0.31
0.75
1.67
2.48
3.14
0.34
Exceptional Items
2.69
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
36.11
36.03
27.53
22.98
19.20
19.50
17.42
Depreciation
2.87
3.35
3.21
3.60
3.73
3.38
1.81
Profit Before Tax
33.24
32.68
24.32
19.38
15.47
16.12
15.60
Tax
12.10
12.11
9.25
6.94
5.36
6.16
5.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.14
20.57
15.07
12.44
10.12
9.96
10.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
-0.33
-0.22
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
21.14
20.57
15.07
12.44
10.12
9.63
10.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.14
20.57
15.07
12.44
10.12
9.63
10.21
Equity Capital
2.92
2.92
2.92
2.92
2.92
2.92
3.03
Face Value
2.0
2.0
2.0
2.0
2.0
10.0
10.0
Reserves
0.00
105.82
0.00
86.32
79.34
0.00
98.22
Earnings per share (EPS)
7.23
7.04
5.16
4.26
3.46
3.41
3.44
Diluted Earnings per share
14.47
14.08
10.31
8.51
6.92
33.57
34.43
Operating Profit Margin (Excl OI)
12.37%
15.66%
13.58%
14.59%
12.0%
12.09%
11.8%
Gross Profit Margin
15.39%
18.4%
15.74%
15.45%
13.24%
13.07%
15.86%
PAT Margin
9.01%
10.51%
8.62%
8.36%
6.97%
6.68%
9.5%
Public Share Holdings (%)
0.0%
49.54%
49.54%
49.14%
49.27%
49.29%
51.39%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 7.26% vs 10.96% in Mar 2024

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 13.03% vs 12.90% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 12.35% vs 16.72% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 37.50% vs 100.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Amrutanjan Healt With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
231.70
0
231.70
Other Operating Income
2.88
0.00
2.88
Total Operating income
234.59
0
234.59
Raw Material Cost
72.83
0
72.83
Purchase of Finished goods
15.68
0
15.68
(Increase) / Decrease In Stocks
-1.93
0
-1.93
Employee Cost
33.58
0
33.58
Power Cost
0.00
0
0.00
Manufacturing Expenses
37.41
0
37.41
Selling and Distribution Expenses
37.38
0
37.38
Other Expenses
10.61
0.00
10.61
Total Expenditure (Excl Depreciation)
205.57
0
205.57
Operating Profit (PBDIT) excl Other Income
29.02
0.00
29.02
Other Income
4.83
0
4.83
Operating Profit (PBDIT)
33.85
0
33.85
Interest
0.43
0
0.43
Exceptional Items
2.69
0
2.69
Gross Profit (PBDT)
36.11
0
36.11
Depreciation
2.87
0
2.87
Profit Before Tax
33.24
0
33.24
Tax
12.10
0
12.10
Provisions and contingencies
0.00
0
0.00
Profit After Tax
21.14
0
21.14
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
21.14
0
21.14
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.14
0
21.14
Equity Capital
2.92
0
2.92
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
7.23
0
7.23
Diluted Earnings per share
14.47
0
14.47
Operating Profit Margin (Excl OI)
12.37%
0%
0.00
12.37%
Gross Profit Margin
15.39%
0%
0.00
15.39%
PAT Margin
9.01%
0%
0.00
9.01%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 451.82 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.26% vs 10.96% in Mar 2024

Annual - Standalone Net Profit
Standalone Net Profit 50.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.03% vs 12.90% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.35% vs 16.72% in Mar 2024

Annual - Interest
Interest 0.22 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.50% vs 100.00% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.88%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024